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Background: Airway epithelium integrity is essential to maintain its role of mechanical and functional barrier.
Recurrent epithelial injuries require a complex mechanism of repair to restore its integrity. In chronic obstructive
pulmonary disease (COPD), an abnormal airway epithelial repair may participate in airway remodeling. The objective
was to determine if airway epithelial wound repair of airway epithelium is abnormal in COPD.
Methods: Patients scheduled for lung resection were prospectively recruited. Demographic, clinical data and
pulmonary function tests results were recorded. Emphysema was visually scored and histological remodeling
features were noted. Primary bronchial epithelial cells (BEC) were extracted and cultured for wound closure assay.
We determined the mean speed of wound closure (MSWC) and cell proliferation index, matrix metalloprotease
(MMP)-2, MMP-9 and cytokines levels in supernatants of BEC 18 hours after cell wounding. In a subset of patients,
bronchiolar epithelial cells were also cultured for wound closure assay for MSWC analyze.
Results: 13 COPD and 7 non COPD patients were included. The severity of airflow obstruction and the severity of
emphysema were associated with a lower MSWC in BEC (p = 0.01, 95% CI [0.15-0.80]; p = 0.04, 95% CI [−0.77;-0.03]
respectively). Cell proliferation index was decreased in COPD patients (19 ± 6% in COPD vs 27 ± 3% in non COPD,
p = 0.04). The severity of COPD was associated with a lower level of MMP-2 (7.8 ± 2 105 AU in COPD GOLD D vs
12.8 ± 0.13 105 AU in COPD GOLD A, p = 0.04) and a lower level of IL-4 (p = 0.03, 95% CI [0.09;0.87]). Moreover,
higher levels of IL-4 and IL-2 were associated with a higher MSWC (p = 0.01, 95% CI [0.17;0.89] and p = 0.02, 95% CI
[0.09;0.87] respectively). Clinical characteristics and smoking history were not associated with MSWC, cell proliferation
index or MMP and cytokines levels. Finally, we showed an association of the MSWC of bronchial and corresponding
bronchiolar epithelial cells obtained from the same patients (p = 0.02, 95% CI [0.12;0.89]).
Conclusion: Our results showed an abnormal bronchial epithelial wound closure process in severe COPD. Further
studies are needed to elucidate the contribution and the regulation of this mechanism in the complex
pathophysiology of COPD.
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Chronic obstructive pulmonary disease (COPD) is a het-
erogeneous disease characterized by progressive airflow
limitation, variously associating airway inflammation and
remodeling, lung parenchymal destruction, systemic in-
flammation and comorbidities as cardiovascular disease
and metabolic syndrome [1,2]. COPD represents a major
worldwide health topic in its morbidity, mortality and its
large consumption of health care resources, with a lim-
ited effect of current treatments [3]. The development of
new therapeutic strategies requires a better understand-
ing of the mechanisms underlying the setting and/or
progression of COPD.
Airway epithelium plays a major role of structural and
functional barrier, preventing inhaled substances from
entering the airway tissue, and coordinating the activities
of cells of the innate and adaptive immune system. Ex-
posure to tobacco smoke, allergens, airborne particu-
lates, infectious agents and noxious gases can induce
injuries of airway epithelium, requiring a regulated repair
mechanism to restore its functionality [4].
After injury, epithelial cells initiate several repair process,
including spreading and migration of cells neighboring the
wound, proliferation, and progressive re-differentiation until
a complete regeneration of a pseudostratified mucociliary
epithelium [4]. Remodeling of large and small airways have
been shown in COPD, including squamous metaplasia,
airway wall fibrosis, goblet cell hyperplasia, submucosal
gland hypertrophy, increase in bronchial smooth muscle
[5]. Chronic and acute injuries by tobacco smoke, environ-
mental irritants, microorganisms are thought to partici-
pate to epithelial remodeling [6]. However, whether there
is an abnormal wound repair process in COPD airways
resulting in altered structure and function of airway epi-
thelium is not established.
To test the hypothesis that wound repair of airway epi-
thelium is abnormal in COPD, we studied primary bron-
chial and bronchiolar epithelial cells from non COPD
and COPD patients in a model of wound closure. The
relationships between airway epithelium wound closure
parameters and clinical, functional and morphological
characteristics of patients were studied.
Methods
Patients
Patients scheduled for lung resection for cancer (University
Hospital of Reims, France) or transplantation (University
Hospital of Grenoble, France) were prospectively recruited
for the study following standards established and approved
by the institutional review board of the university hospital
of Reims, France. Informed consent was obtained from all
the patients. Patients with asthma, cystic fibrosis, bronchi-
ectasis or pulmonary fibrosis were excluded. At inclusion,
the following characteristics were recorded: age, sex, bodymass index (BMI), smoking history, arterial blood gases
and pulmonary function tests results. No patient was
treated by N-acetyl cysteine. COPD was defined by post-
bronchodilator FEV1/FVC < 70% [2]. The severity of COPD
was determined by spirometric classification (GOLD 1:
FEV1 ≥ 80% predicted, GOLD 2: 50% ≤ FEV1 < 80% pre-
dicted, GOLD 3: 30% ≤ FEV1 < 50% predicted, GOLD 4:
FEV1 < 30% predicted) and by the GOLD combined score
(A, B, C, D) (GOLD 2014).
CT-scan were analyzed by two independent investiga-
tors (JMP, GD) using a visual emphysema quantification
on resected lung from 0 to 4 as previously described [7].
Cell culture and wound closure assay
Primary bronchial epithelial cells were extracted from
resected lungs distant to the tumor as previously described
[8]. Briefly, bronchi were visually identified and mechanic-
ally dissected. Dissected bronchi were transferred in RPMI
medium supplemented with 20 mM HEPES (Gibco, Paisley,
UK) and antibiotics (200 UI/ml penicillin, 200 Ag/ml
streptomycin; Gibco) and then dissociated by 0.05% type
XIV collagenase (Pronase E, Sigma Aldrich, St Louis, MO)
and incubated in RPMI-HEPES overnight at 4°C. Cells were
counted and seeded into flasks coated with type IV collagen
(Sigma, Aldrich) with the CnT-17 proliferating medium
(CELLnTEc, Bern, Switzerland). Cells were then passed into
a 12-well plate coated with type IV collagen and cultured in
bronchial epithelial cell growth medium (BEGM) (Lonza,
Walkersville, MD).
When confluent and with a similar density, cells were
used for wound closure assay by a mechanical injury using
a P10 pipette tip as previously described [8]. Cells were
washed with PBS and culture media was added. As feasi-
bility experiments had shown that most of wounded areas
of non-COPD patients were closed 18 hours after wound-
ing, the closure of wound area was monitored for 18 hours
using a digital camera and Axiovision software (Carl Zeiss
Vision GmbH, Munchen-Hallbermoos, Germany) at the
start of the experiment and each 10 minutes. The wound
closure assays were performed in triplicate in separate
wells. Images were used to determine wound repair, calcu-
lated as percent wound area compared with the initial
wound area. We determined the mean speed of wound
closure using Image J software (National Institutes of
Health, Bethesda, MD, USA).
Seven samples (2 non COPD patients, 2 COPD GOLD
II, 3 COPD GOLD IV) have been excluded because of cell
culture failure: absence of initial cell proliferation (n = 5),
cell death after injury (n = 1), fungal contamination (n = 1).
We analysed cell growth in the initial culture depending
on COPD status and severity. The time to confluence was:
7.28 ± 1.97 days in non COPD group, 7.73 ± 3.13 days in
COPD group, 6 ± 2.82 days in COPD GOLD I, 7.5 ±
3.11 days in COPD GOLD II, 10.33 ± 2.52 days in COPD
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nificant level.
In a subset of patients, bronchiolar epithelial cells were
also extracted from resected lungs. Briefly, bronchioles
were identified on the basis of absence of wall cartilage
and an outer diameter ≤1 mm [9], and then mechanic-
ally dissected. Bronchiolar epithelial cells were obtained
from bronchioles following the same process as bronchi
then cultured and used for wound closure assay as de-
scribed above.
Immunofluorescence
Bronchial and bronchiolar epithelial cells were cultured
on glass coverslips coated with Purecol bovine collagen
solution (3 mg/ml) diluted 1:75 in sterile water. When
confluent, mechanical injury was performed on cell mono-
layer as described above. Cells were then fixed with
methanol immediately after (T0) and 18 hours (T18) after
the mechanical injury. In order to analyze the dynamics
of wound closure parameters, we analysed 2 other time
points at 6 (T6) and 12 hours (T12) after wounding. Fixed
cells were blocked with 3% bovine serum albumin for
60 min. The coverslips were incubated with a mouse mono-
clonal antibody against Ki-67 (1:100) (Dako, Denmark),
then with Alexa Fluor 488 coupled mouse anti-IgG (1:200)
(Molecular Probes, Eugene, OR, USA). Nuclei were stained
with 4′,6-diamidino-6-phenylindole (DAPI, Molecular Probes,
Eugene, OR, USA). The results are presented as a percent-
age of Ki-67 positive proliferating cells compared with
total cells.
Gelatin zymography analysis
Supernatants of bronchial epithelial cell cultures at T6,
T12 and T18 were collected, centrifugated and separated
on 10% polyacrylamide SDS gel containing 0.1% gelatin.
The gel was washed for 1 h at room temperature in a
2% Triton X-100 solution, transferred to a 50 mm Tris–
HCl/10 mm CaCl2 (pH 7.6) buffer and incubated over-
night at 37°C. The gel was stained in a 0.1% Coomassie
Blue (G250)/45% methanol/10% acetic acid solution and
de-stained in a 10% acetic acid/20% methanol solution.
The gel was then analyzed by densitometry performed
using Multigauge V2.02 (Fuji film, Stamford, CT, USA).
Cytokine analysis
Supernatants of bronchial epithelial cell cultures at T18
were tested for cytokine detection (Interleukin (IL)-2,
IL-4, IL-5, IL-6, IL-8, IL-10, IL-1β, IFN-γ, GM-CSF, TNF-α)
using Human Cytokine Ten-Plex kit (Invitrogen, Carlsbad,
CA) following manufacturer’s recommendations.
Histological analysis
Part of resected lungs were fixed in formalin and embed-
ded in paraffin before cutting into serial 5 μm sectionand staining with hematoxylin and eosin, then observed
on microscope (x100). Bronchial epithelium was analyzed
in 10 different areas in 4 to 7 bronchi per patient. The
following major remodeling features were quantified:
denuded basement membrane, goblet cell hyperplasia, basal
cell hyperplasia and squamous metaplasia. Squamous
cell metaplasia was defined as a pseudostratified multi-
layered epithelium consisting of polygonal cells covered
by flattened layer of squamous cells and absence of ciliated
cell [10]. The predominant remodeling feature was attrib-
uted to each observed area. Results were expressed as the
percentage of remodeling feature per all observed areas
per lung.
Statistical analysis
The data are expressed as mean values ± standard deviation
or percentages. We compared wound closure parameters
(mean speed of wound closure, cell proliferation index,
MMPs and cytokines levels) between groups (COPD status,
chronic bronchitis) using the Student t test or Fisher exact
test. We studied correlations between wound closure pa-
rameters and clinical and functional data (FEV1, FEV1/FVC,
emphysema score, age, BMI, smoking history, dyspnea
score, number of exacerbations) using the Pearson correl-
ation test. A p-value < 0.05 was considered significant.
Results
Patients’ characteristics
Twenty patients were included, 13 COPD patients and 7
non COPD patients. Eighteen patients underwent lung
resection for lung cancer (n = 17) or kidney cancer me-
tastasis (n = 1). Two patients had lung transplantation
for emphysema. Characteristics of patients are detailed
in Table 1. Pre-operative arterial blood gases were avail-
able for 11 patients. COPD patients had a lower PaO2
level compared to non COPD patients (74 ± 11 vs 90 ±
9 mmHg respectively, p = 0.02).
A visual quantification of remodelling features was per-
formed in 17 lungs. We found the main remodelling fea-
ture was goblet cell hyperplasia (51.7 ± 23.4 and 48.6 ±
24.4% of epithelium surface in non COPD and COPD
groups respectively). Basal cell hyperplasia was found in
12.6 ± 22.2% of epithelium surface in COPD group. How-
ever, the percentage of epithelium surface with remodel-
ling features was not statistically different between COPD
and non-COPD groups in our series.
Bronchial wound closure and associations with clinical,
functional and histological characteristics
To determine if bronchial wound closure is delayed in
COPD, we analysed the speed of wound closure in pri-
mary bronchial epithelial cells using a wound closure
assay (Figure 1A). Overall, the MSWC of COPD and
non COPD patients did not significantly differ (9997 ±
Table 1 Characteristics of patients
Non COPD COPD p
n 7 13
Male gender 71% 85% ns
Age, years 69 ± 10 [58–87] 66 ± 10 [52–84] ns
BMI, kg/m2 33 ± 9 [26–43] 25 ± 4 [19–35] 0.04
Smoking history
Never smokers 29% 0% ns
Ex smokers 43% 54% ns
Pack-years 29 ± 25 [0–60] 54 ± 22 [25–100] ns
Symptoms
Dyspnea ≥2 mMRC 0% 31% ns
Chronic bronchitis 14% 31% ns
At least one exacerbation
in the last year
na 31%
Spirometry
FEV1,% of predicted value 94 ± 15 [72–113] 68 ± 29 [17–109] 0.04
FVC,% of predicted value 90 ± 13 [77–114] 89 ± 23 [54–117] ns
FEV1/FVC,% 77 ± 5 [73–87] 59 ± 17 [27–69] 0.01
Spirometric GOLD 1/2/3-4 na 5/5/3
GOLD A/B/C/D na 5/5/0/3
CT emphysema score for the
resected lobe
0.4 + 0.8 [0–2] 1.3 + 1.7 [0–4] ns
Histological analyses,% of
epithelial surface, n = 17
Denuded basement
membrane
3.8 ± 5.0 [0–13] 5.4 ± 4.0 [0–14] ns
Goblet cell hyperplasia 51.7 ± 23.4 [7–80] 48.6 ±24.4 [16–82] ns
Basal cell hyperplasia 4.2 ± 4.6 [0–14] 12.6 ± 22.2 [0–70] ns
Squamous metaplasia 2.2 ± 1.8 [0–5] 2.1 ± 3.2 [0–9] ns
Normal 38.0 ± 22.2 [10–87] 32.7 ± 23.0 [3–66] ns
Data are expressed as mean ± SD or number (%).
FEV1: Forced Expiratory Volume in one second. FVC: Forced Vital Capacity.
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as shown in Figure 1B, we found that the mean speed of
wound closure (MSWC) was dramatically decreased
in spirometric COPD GOLD 3–4 compared to non
COPD patients (4165 ± 743 μm2/h vs 11338 ± 3552 μm2/h,
p = 0.006). Interestingly, the severity of airflow obstruction
(FEV1 and FEV1/FVC) was associated with a lower MSWC
(Table 2, Figure 2). Analysis of the subgroup of COPD
patients confirmed the association between FEV1 and
MSWC (p < 0.05). FEV1 was also associated with the per-
centage of wound area at T18 (p = 0.02, 95% CI [0.06;
0.77]). The severity of emphysema assessed by a visual
score was associated with a lower MSWC (Table 2). Of
notes, the MSWC was not associated with age, BMI,
smoking history, dyspnea, chronic bronchitis or the num-
ber of exacerbations in the past year. Analysis of remodel-
ling features showed that the MSWC was not associatedwith the percentage of denuded basement membrane
(p = 0.22), goblet cell hyperplasia (p = 0.71), basal cell
hyperplasia (p = 0.07), squamous metaplasia (p = 0.50) and
normal epithelium (p = 0.61).
Cell proliferation during bronchial epithelial cells wound
closure assay
We next analysed cell proliferation during bronchial
wound closure (n = 11). We performed Ki-67 and DAPI
staining at T0, T6, T12 and T18 and determined the per-
centage of Ki-67 positive proliferating cells compared with
total cells (cell proliferation index; Figure 3A). Interest-
ingly, cell proliferation at T18 was significantly lower in
COPD patients compared to non COPD patients (19 ± 6%
vs 27 ± 3% respectively, p = 0.04; Figure 3B). Analysis of
subgroup of COPD patients showed that cell proliferation
index in COPD GOLD 3–4 patients was significantly
lower compared to non COPD patients (19% ± 0.6% vs
27% ±3% respectively, p = 0.02). Cell proliferation index in
COPD GOLD 1 and COPD GOLD 2 patients did not sig-
nificantly differ from non COPD patients (18% ± 10% and
22% ± 6% vs 27% ± 3% respectively, ns).
We next studied associations between cell prolifera-
tion and clinical characteristics of patients. Cell prolifer-
ation index at T18 was not associated with age, BMI,
smoking history, dyspnea, chronic bronchitis or the
number of exacerbations in the past year (Additional
file 1: Table S1). Analysis of remodelling features showed
that cell proliferation index was associated with the per-
centage of goblet cell hyperplasia (p = 0.03, 95% CI
[0.06;0.93]) but not with denuded basement membrane,
basal cell hyperplasia, squamous metaplasia or normal
epithelium.
Finally, we studied association between cell prolifera-
tion index and the speed of wound closure. We found
that cell proliferation at T18 was not associated with the
MSWC (p = 0.76). We further analysed cell proliferation
at T0, T6 and T12 and did not find any association
between cell proliferation index at T0, T6 and T12 and
the percentage of wound closure at T6, T12 and T18
respectively.
MMP-9 and MMP-2 levels during bronchial epithelial cells
wound closure assay
We next analysed MMP-9 and MMP-2 levels in super-
natants of bronchial epithelial cell cultures by gelatine
zymography at T6, T12 and T18. Analysis of clinical
characteristics of patients showed that MMP-9 level at
T18 was negatively associated with the number of ex-
acerbation in the past year (p = 0.04, 95% CI [−0.87;-
0.04]) and positively associated with age (p = 0.02, 95%
CI [0.11;0.85] but not with BMI, smoking history, dys-
pnea and chronic bronchitis (Additional file 2: Table S2).
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Figure 1 Wound closure assay in bronchial epithelial cells from COPD and non COPD patients. A mechanical injury was performed on
confluent bronchial epithelial cell monolayer. Representative photographs at 0, 6, 12 and 18 h in a non COPD and a COPD GOLD D spirometric
GOLD 3 patient (A). The mean percentage of remaining wound area in non COPD patients (n = 7), spirometric COPD GOLD 1 (n = 5), GOLD 2
(n = 5) and GOLD 3–4 patients (n = 3) are presented (B). *p < 0.05 vs non COPD.
Table 2 Associations between the mean speed of wound
closure of bronchial epithelial cells and clinical,
functional and morphological characteristics of patients
P 95% Cl
FEV1, % of predicted value 0.01 0.15;0.80
FEV1/FVC, % 0.04 0.03;0.76
CT emphysema score for the resected lobe 0.04 -0.77;-0.03
Age, years 0.21 -0.17;0.64
BMI, kg/m² 0.76 -0.59;0.46
Smoking history, pack-years 0.16 -0.14;0.70
Dyspnea, mMRC 0.75 -0.59;0.46
Chronic bronchitis 0.60
Exacerbation in the past year, n 0.31 -0.67;0.26
FEV1: Forced Expiratory Volume in one second, FVC: Forced Vital Capacity.
Pearson or Student tests were performed.
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smoking history, dyspnea, chronic bronchitis and the
number of exacerbation in the past year (Additional
file 2: Table S2). Interestingly, we found that MMP-2
level at T18 was significantly associated with the severity
of airway obstruction (FEV1/FVC, p = 0.02, 95% CI
[0.11;0.86] and was lower in GOLD D patients compared
to GOLD A patients (7.8 ± 2 105 AU vs 12.8 ± 0.13
105 AU, p = 0.04). We did not find any association be-
tween MMP-9 levels at T18 and COPD status, COPD se-
verity or emphysema (Additional file 2: Table S2). Analysis
of remodelling features showed that MMP-9 and MMP-
2 levels at T18 were not associated with the percentage
of denuded basement membrane, goblet cell hyperpla-
sia, basal cell hyperplasia, squamous metaplasia or
normal epithelium. Levels of MMP-9 and MMP-2 in cells
20


















Figure 2 Relationships between mean speed of bronchial
epithelial wound closure and FEV1. Bronchial epithelial wound
closure in non COPD (triangle, n = 7) and COPD patients (square, n
= 13) was monitored for 18 h, and the mean speed of wound
closure (MSWC) was calculated. p = 0.01.
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ical, functional, morphological and histological character-
istics of patients (not shown).
Finally, we studied the associations between MMP-9
and MMP-2 levels and the speed of wound closure. We
found that MMP-9 and MMP-2 levels at T6, T12 and




Figure 3 Cell proliferation during epithelial wound closure in non CO
enlargement) of Ki-67 and DAPI staining, as well as merge images in non C
tification of the number of Ki-67 positive cells expressed as a percentage opercentage of wound closure at T6, T12 and T18 re-
spectively (not shown).
Cytokine secretions during bronchial epithelial cells
wound closure assay
We next analyzed pro-inflammatory cytokines levels in
bronchial epithelial cell supernatants at T18. We found
that the severity of airflow limitation (FEV1) was associ-
ated with a lower level of IL-4 (p = 0.03, 95% CI
[0.09;0.87]; Additional file 3: Table S3). The levels of IL-
2, IL-4, IL-10 and GM-CSF were associated with an
older age of patients (p < 0.05 for all). Cytokine levels in
bronchial cell supernatants at T18 were not associated
with smoking history or respiratory symptoms. Analysis
of remodelling features showed that IL-8 level was asso-
ciated with squamous metaplasia (p = 0.01, 95% CI
[0.24;0.92]). IL-2 level was associated with goblet cell
hyperplasia (p = 0.03, 95% CI [0.06;0.90]).
We further studied the associations between cytokines
levels and the speed of wound closure. Interestingly, higher
levels of IL-4, IL-2 and GM-CSF were associated with a
higher MSWC (p = 0.01, 95% CI [0.17;0.89]; p = 0.02, 95%
CI [0.09;0.87]; p = 0.03, 95% CI [0.07;0.86] respectively).
Bronchiolar epithelial cells wound closure assay
In order to determine if bronchiolar epithelial cells wound
closure is similar to bronchial epithelial cells wound clos-































PD and COPD patients. Representative photographs (x10
OPD and COPD bronchial epithelial cells after 18 h of repair (A). Quan-
f total cell number at 0 h, 6 h, 12 h and 18 h of repair (B).
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tients and 6 COPD patients (4 COPD GOLD 1, 1 COPD
GOLD 2, 1 COPD GOLD 3; Additional file 4: Table S4).
Overall, the MSWC of bronchiolar epithelial cells was
significantly lower compared to bronchial epithelial
cells (9658 ± 3306 vs 13783 ± 5603 μm2/h respectively,
p = 0.048). Analysis of paired bronchial and bronchiolar
cells obtained from corresponding patient (n = 12) showed
that the MSWC of bronchial and bronchiolar epithelial
cells were associated (p = 0.02, 95% CI [0.12;0.89]; Figure 4).
The MSWC of bronchiolar epithelial cells was not associ-
ated with COPD status or severity.
Discussion
We showed in this study performed in primary bron-
chial epithelial cells obtained from 20 patients clinic-
ally, functionally and histologically characterised that
the mean speed of epithelial wound closure decreased
with the severity of COPD. We also showed that the






















































Figure 4 Association between the mean speed of bronchiolar and bro
epithelial cells were obtained in 12 patients and analysed in wound closure
a COPD GOLD D spirometric GOLD 3 patient (A) are presented. The associ
epithelial cells and corresponding bronchial epithelial cells is shown (B). pepithelial cells obtained from the same patients were
strongly associated.
Repair of airway epithelium after injury is critical for
the maintenance of the airway epithelial structure and
function. In our study, we analyzed bronchial epithelium
repair in the first steps of airway epithelial repair process:
migration and proliferation. These processes follow the
epithelial to mesenchymal transition, a dedifferentiation of
epithelial cells to motile mesenchymal cells playing a key
role in degradation and de novo synthesis of extracellular
matrix [6]. One of the most striking findings in our study
is that the delay of bronchial epithelial wound closure was
associated with the severity of airflow obstruction. More-
over, we showed that COPD was associated with a de-
creased cell proliferation index 18 hours after bronchial
epithelial cell wounding, and that cell proliferation index
was not associated with the delay of bronchial epithelial
cells wound closure. Several important limitations regard-
ing the selection of the patients have to be considered in
our study. First, a relatively low number of patients wereCOPD GOLD D, spirometric GOLD3
0h 18h 





nchial epithelial wound closure. Paired bronchial and bronchiolar
assay. Representative photographs at 0 and 18 h in a non COPD and
ation between the mean speed of wound closure of bronchiolar
= 0.02.
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were obtained mainly from lung sections distant from lung
cancer. Third, the non-COPD population included ex and
current smokers. However, our results strongly suggest
that abnormalities in the first steps of airway epithelial
repair process may be involved in severe COPD. Add-
itional studies including a higher number of patients
and using differentiated airway epithelial cells in the air
liquid interface culture model would allow analyzing all
different sequential steps of the repair process.
COPD is of high heterogeneity and its evaluation can
not be restricted to a threshold of lung function meas-
urement. We further analyzed parameters of clinical
phenotypes of COPD patients. Interestingly, previous
studies showed that airway epithelial cells repair could
be impaired by senescence of airway epithelial cells or
cigarette smoke exposure [11,12]. In our study, we did
not find any association between MSWC or cell prolifer-
ation index and the following clinical characteristics of
patients: age, BMI, smoking history, respiratory symp-
toms and the number of exacerbation in the previous
year. Surprisingly, we did not find any statistical differ-
ence in airway remodeling features between COPD and
non COPD group in our study. This could be explained
by the high rate of ex or current smokers in the non
COPD group, by the major heterogeneity of airway re-
modeling features distribution in COPD and by the rela-
tively low number of patients analysed. In our study,
goblet cell hyperplasia was associated with a higher cell
proliferation index and a higher IL-2 level at T18. Squa-
mous metaplasia was associated with a higher level of
IL-8. Previous studies reported the role of cigarette
smoke-mediated pro-inflammatory cytokines in the de-
velopment of bronchial epithelial hyperplasia and squa-
mous metaplasia [13]. Of notes, the MSWC was not
associated with bronchial epithelial remodeling features
in our study.
We analyzed MMP-2 and MMP-9 levels during wound
closure assay. MMP-2 and MMP-9 have been shown to
be involved in the pathogenesis of COPD [14,15]. These
proteases could play a role in epithelial repair process.
During epithelial repair, MMP-9 is secreted by transdif-
ferentiated cells and degrades focal adhesion at the rear
of the cell [16]. Moreover, inactivation of MMP-9 has
been shown to decrease the migration of bronchial epi-
thelial cells [17]. Previous studies showed an association
between MMP-2 level and airway obstruction [18]. In
our study, we found that MMP-2 level decreased in se-
vere GOLD D COPD at T18, which may play a role in
impaired bronchial epithelium repair in severe COPD.
Interestingly, we found that a lower level of MMP-9 at
T18 was associated with a higher frequency of exacerba-
tion. However, we did not find any association between
MMP-2 and MMP-9 levels and the MSWC in our study.Numbers of cytokines have been shown to be involved
in repair processes in the lung [19]. White and collabo-
rators [20] found that IL-4 stimulated the migration and
repair of differentiated primary human bronchial epithe-
lial cells. IL-2 was shown to increase the migration of in-
jured rat alveolar type II cells, and reduce apoptosis of
these cells [21]. Interestingly, we found that higher levels
of IL-4, IL-2 and GM-CSF were associated with a higher
MSWC. Moreover, we found that IL-4 level in bronchial
epithelial cells wound closure assay decreased with the
severity of airway obstruction, suggesting that IL-4 could
be involved in abnormal bronchial epithelial repair in
COPD. Finally, a lower level of IL-4 was associated with
a higher frequency of exacerbation. Further studies should
explore the potential role of IL-4 as a mechanism under-
lying delayed repair. As previously described, we found
that several cytokines were at a higher levels in older
patients [22].
Finally, we analyzed bronchiolar epithelial cells in
wound closure assay. Recent studies based on micro-CT
imaging and histology showed a decrease in the number
and the mean diameter of remodeled bronchioles in
COPD [23]. A recent review suggested that bronchiolar
remodeling and destruction could be involved in COPD
[24]. One of the strength of our study is that we studied
paired bronchial and bronchiolar epithelial cells from
the same patients in a wound closure assay. We did not
find any association between the MSWC of bronchiolar
epithelial cells and COPD status or severity, probably be-
cause of a low number of patients and the fact that we
did not obtain bronchiolar epithelial cells from the most
severe patients. However, we showed that the MSWC of
bronchiolar epithelial cells was strongly associated with
corresponding bronchial epithelial cells.
In conclusion, our results showed that the first steps
of bronchial epithelial repair are impaired in severe
COPD, possibly involving MMP-2 and IL-4 and IL-10.
Our results also suggest that an abnormal bronchiolar
epithelium repair could be involved in COPD. Further
studies are needed to determine the exact role of bron-
chial and bronchiolar epithelial repair after repeated in-
juries in the pathophysiology of COPD.Additional files
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Additional file 2: Table S2. Associations between MMP-9 and MMP-2
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supernatants of bronchial epithelial cells at T18 and clinical, functional
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Perotin et al. Respiratory Research 2014, 15:151 Page 9 of 9
http://respiratory-research.com/content/15/1/151Additional file 4: Table S4. Histological analyses of bronchiolar
samples, n=10.
Abbreviations
COPD: Chronic obstructive pulmonary disease; FEV1: Forced expiratory
volume in one second; FVC: Forced vital capacity; TNF: Tumor necrosis factor;
IL: Interleukin; IFN: Interferon; BMI: Body mass index; MSWC: Mean speed of
wound closure; MMP: Matrix metalloproteinase; LPS: Lipopolysaccharide.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
JMP coordinated the study, carried out cell experiments, performed statistical
analysis and draft the manuscript. DA participated in the design of the study,
carried out cells extractions and participated to cell cultures. JVB participated
to cell culture and wound closure assay. ACJ, AP, GB, CP and FL selected and
characterized patients. GDelepine and SS performed lung resections. PB
participated in the design of the study and its coordination and performed
histological analysis. CC participated in the design of the study and its
coordination and carried out cells extractions. GDeslee conceived the study
and participated in its design and coordination and helped to draft the
manuscript. All authors read and approved the final manuscript.
Acknowledgments
Authors thank the Plateforme en Imagerie Cellulaire et Tissulaire of the
university of Reims, France for their technical support in cell imaging.
Fundings
This work has been supported by a grant from the University Hospital of
Reims (Appel d’Offre Local 2011).
Author details
1Department of Respiratory Diseases, University Hospital, 45 rue Cognacq Jay,
51100 Reims, France. 2INSERM UMRS 903, University Hospital, Reims, France.
3Department of Cardio-Thoracic Surgery, University Hospital, Reims, France.
4Department of Respiratory Medicine, Hospital, Charlevilles-Mezières, France.
5Institut Jean Godinot, Reims, France. 6Department of Respiratory Medicine,
Hospital, Chalons en Champagne, France. 7Clinique Universitaire de
Pneumologie, Pôle Thorax et Vaisseaux, CHU Grenoble; Inserm1055;
Université Joseph Fourier, Grenoble, France. 8Department of
anatomopathology, Pol Bouin Laboratory, University Hospital, Reims, France.
Received: 20 May 2014 Accepted: 11 November 2014
References
1. Nussbaumer-Ochsner Y, Rabe KF: Systemic manifestations of COPD.
Chest 2011, 139:165–173.
2. Global Strategy for the Diagnosis, Management and Prevention of
COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD)
2014. [http://www.goldcopd.org/]
3. Halpin DM, Miravittles M: Chronic obstructive pulmonary disease: the
disease and its burden to society. Proc Am Thorac Soc 2006, 3:619–623.
4. Grainge CL, Davies DE: Epithelial injury and repair in airways diseases.
Chest 2013, 144:1906–1912.
5. Hirota N, Martin JG: Mechanisms of airway remodeling. Chest 2013,
144:1026–1032.
6. Ganesan S, Sajjan US: Repair and remodeling of airway epithelium after
injury in chronic obstructive pulmonary disease. Curr Respir Care Rep 2013,
2:145–154.
7. Washko GR, Criner GJ, Mohsenifar Z, Sciurba FC, Sharafkhaneh A, Make BJ,
Hoffman EA, Reilly JJ: Computed tomographic-based quantification of
emphysema and correlation to pulmonary function and mechanics.
COPD 2008, 5:177–186.
8. Trinh NT, Bardou O, Privé A, Maillé E, Adam D, Lingée S, Ferraro P,
Desrosiers MY, Coraux C, Brochiero E: Improvement of defective cystic
fibrosis airway epithelial wound repair after CFTR rescue. Eur Respir J
2012, 40:1390–1400.9. Bals R, Beisswenger C, Blouquit S, Chinet T: Isolation and air-liquid interface
culture of human large airway and bronchiolar epithelial cells. J Cyst
Fibros 2004, 3:49–51.
10. Lapperre TS, Sont JK, van Schadewijk A, Gosman MM, Postma DS, Bajema
IM, Timens W, Mauad T, Hiemstra PS, GLUCOLD Study Group: Smoking
cessation and bronchial epithelial remodelling in COPD: a cross-sectional
study. Respir Res 2007, 8:85.
11. Zhou F, Onizawa S, Nagai A, Aoshiba K: Epithelial cell senescence impairs
repair process and exacerbates inflammation after airway injury. Respir
Res 2011, 12:78.
12. Allen-Gipson DS, Zimmerman MC, Zhang H, Castellanos G, O’Malley JK,
Alvarez-Ramirez H, Kharbanda K, Sisson JH, Wyatt TA: Smoke extract
impairs adenosine wound healing: implications of smoke-generated
reactive oxygen species. Am J Respir Cell Mol Biol 2013, 48:665–673.
13. Herfs M, Hubert P, Poirrier AL, Vandevenne P, Renoux V, Habraken Y,
Cataldo D, Boniver J, Delvenne P: Proinflammatory cytokines induce
bronchial hyperplasia and squamous metaplasia in smokers: implications
for chronic obstructive pulmonary disease therapy. Am J Respir Cell Mol
Biol 2012, 47:67–79.
14. Elkington PT, Friedland JS: Matrix metalloproteinases in destructive
pulmonary pathology. Thorax 2006, 61:259–266.
15. Atkinson JJ, Lutey BA, Suzuki Y, Toennies HM, Kelley DG, Kobayashi DK, Ijem
WG, Deslee G, Moore CH, Jacobs ME, Conradi SH, Gierada DS, Pierce RA,
Betsuyaku T, Senior RM: The role of matrix metalloproteinase-9 in
cigarette smoke-induced emphysema. Am J Respir Crit Care Med 2011,
183:876–884.
16. Buisson AC, Zahm JM, Polette M, Pierrot D, Bellon G, Puchelle E, Birembaut
P, Tournier JM: Gelatinase B is involved in the in vitro wound repair of
human respiratory epithelium. J Cell Physiol 1996, 166:413–426.
17. Legrand C, Gilles C, Zahm JM, Polette M, Buisson AC, Kaplan H, Birembaut P,
Tournier JM: Airway epithelial cell migration dynamics. MMP-9 role in
cell-extracellular matrix remodeling. J Cell Biol 1999, 146:517–529.
18. Baraldo S, Bazzan E, Zanin ME, Turato G, Garbisa S, Maestrelli P, Papi A, Miniati
M, Fabbri LM, Zuin R, Saetta M: Matrix metalloproteinase-2 protein in lung
periphery is related to COPD progression. Chest 2007, 132:1733–1740.
19. Crosby LM, Waters CM: Epithelial repair mechanisms in the lung.
Am J Physiol Lung Cell Mol Physiol 2010, 298:L715–L731.
20. White SR, Martin LD, Abe MK, Marroquin BA, Stern R, Fu X: Insulin receptor
substrate-1/2 mediates IL-4-induced migration of human airway
epithelial cells. Am J Physiol Lung Cell Mol Physiol 2009, 297:L164–L173.
21. Lesur O, Brisebois M, Thibodeau A, Chagnon F, Lane D, Fullop T: Role of
IFN-gamma and IL-2 in rat lung epithelial cell migration and apoptosis
after oxidant injury. Am J Physiol Lung Cell Mol Physiol 2004, 286:L4–L14.
22. Sharma G, Hanania NA, Shim YM: The aging immune system and its
relationship to the development of chronic obstructive pulmonary
disease. Proc Am Thorac Soc 2009, 6:573–580.
23. McDonough JE, Yuan R, Suzuki M, Seyednejad N, Elliott WM, Sanchez PG,
Wright AC, Gefter WB, Litzky L, Coxson HO, Paré PD, Sin DD, Pierce RA,
Woods JC, McWilliams AM, Mayo JR, Lam SC, Cooper JD, Hogg JC:
Small-airway obstruction and emphysema in chronic obstructive
pulmonary disease. N Engl J Med 2011, 365:1567–1575.
24. Hogg JC, McDonough JE, Suzuki M: Small airway obstruction in COPD:
new insights based on micro-CT imaging and MRI imaging. Chest 2013,
143:1436–1443.
doi:10.1186/s12931-014-0151-9
Cite this article as: Perotin et al.: Delay of airway epithelial wound repair
in COPD is associated with airflow obstruction severity. Respiratory
Research 2014 15:151.
